Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)

Clinical trial NCT01039103 · TERMINATED

Trial details

NCT number: NCT01039103
Sponsor: Lakefront Biotherapeutics NV
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Exacerbation of Remitting Relapsing Multiple Sclerosis Clinically Isolated Syndrome

Start date: 2009-12-01
Primary completion: 2011-11-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.